Investigation on new paradigm of clinical physiological monitoring by using wearable devices.
10.7507/1001-5515.202010021
- Author:
Zhao WANG
1
;
Hong LIANG
2
;
Jiachen WANG
1
;
Yaning ZANG
3
;
Haoran XU
1
;
Ke LAN
4
;
Maoqing HE
4
;
Wei YAN
5
;
Desen CAO
6
;
Muyang YAN
5
;
Zhengbo ZHANG
2
Author Information
1. Medical School of Chinese PLA, Beijing 100853, P.R.China.
2. Center for Artificial Intelligence in Medicine, Chinese PLA General Hospital, Beijing 100853, P.R.China.
3. School of kinesiology, Shanghai University of Sport, Shanghai 200438, P.R.China.
4. Beijing SensEcho Science & Technology Co., Ltd., Beijing 100853, P.R.China.
5. Department of Hyperbaric Oxygen, Chinese PLA General Hospital, Beijing 100853, P.R.China.
6. Department of Biomedical Engineering, Chinese PLA General Hospital, Beijing 100853, P.R.China.
- Publication Type:Journal Article
- Keywords:
clinical application research;
physiological parameter analysis;
real-time monitoring;
wearable devices
- MeSH:
Heart Rate;
Humans;
Monitoring, Physiologic;
Movement;
Sleep Apnea Syndromes;
Wearable Electronic Devices
- From:
Journal of Biomedical Engineering
2021;38(4):753-763
- CountryChina
- Language:Chinese
-
Abstract:
As a low-load physiological monitoring technology, wearable devices can provide new methods for monitoring, evaluating and managing chronic diseases, which is a direction for the future development of monitoring technology. However, as a new type of monitoring technology, its clinical application mode and value are still unclear and need to be further explored. In this study, a central monitoring system based on wearable devices was built in the general ward (non-ICU ward) of PLA General Hospital, the value points of clinical application of wearable physiological monitoring technology were analyzed, and the system was combined with the treatment process and applied to clinical monitoring. The system is able to effectively collect data such as electrocardiogram, respiration, blood oxygen, pulse rate, and body position/movement to achieve real-time monitoring, prediction and early warning, and condition assessment. And since its operation from March 2018, 1 268 people (657 patients) have undergone wearable continuous physiological monitoring until January 2020, with data from a total of 1 198 people (632 cases) screened for signals through signal quality algorithms and manual interpretation were available for analysis, accounting for 94.48 % (96.19%) of the total. Through continuous physiological data analysis and manual correction, sleep apnea event, nocturnal hypoxemia, tachycardia, and ventricular premature beats were detected in 232 (36.65%), 58 (9.16%), 30 (4.74%), and 42 (6.64%) of the total patients, while the number of these abnormal events recorded in the archives was 4 (0.63%), 0 (0.00%), 24 (3.80%), and 15 (2.37%) cases. The statistical analysis of sleep apnea event outcomes revealed that patients with chronic diseases were more likely to have sleep apnea events than healthy individuals, and the incidence was higher in men (62.93%) than in women (37.07%). The results indicate that wearable physiological monitoring technology can provide a new monitoring mode for inpatients, capturing more abnormal events and provide richer information for clinical diagnosis and treatment through continuous physiological parameter analysis, and can be effectively integrated into existing medical processes. We will continue to explore the applicability of this new monitoring mode in different clinical scenarios to further enrich the clinical application of wearable technology and provide richer tools and methods for the monitoring, evaluation and management of chronic diseases.
